试验论文中资助方与作者经济利益冲突信息的报告充分性及缺失信息获取情况
该研究从2022年5月MEDLINE索引的随机试验论文中随机抽取200篇,由两名作者独立评估资助方与作者经济利益冲突信息的报告充分性,并尝试通过多种途径获取缺失信息。结果显示资助方信息充分报告仅67篇(34%),而作者经济利益冲突信息充分报告达180篇(90%),获取资助方缺失信息的中位时间为每篇13分钟,获取作者利益冲突缺失信息的中位时间为每篇28分钟。
要点
- 资助方信息充分报告仅34%,常缺支持类型(40%)和资助方对试验设计、实施、分析、报告的参与(58%)。
- 作者经济利益冲突信息充分报告达90%,缺失信息获取成功率较低且更耗时。
- 获取缺失信息后资助方信息充分比例提高32%,中位耗时13分钟/篇。
核心结论
- 当代试验论文中资助方信息很少充分报告,而作者经济利益冲突信息在几乎所有试验论文中均充分报告。
- 获取缺失信息的方法提高了资助方和利益冲突信息的充分性,对资助方信息尤其有效。
- 获取利益冲突信息的努力成功率较低且更耗时。
研究设计与样本
- 从2022年5月MEDLINE索引的随机试验论文中随机抽取200篇。
- 两名作者独立评估资助方与作者经济利益冲突信息的报告充分性。
- 通过多种途径(如检索网站、试验注册库和公开披露数据库)尝试获取缺失信息并记录耗时。
主要发现
- 资助方信息充分报告67篇(34%),部分充分110篇(55%),不充分12篇(6%),无可用信息11篇(6%)。
- 试验论文常未报告支持类型(40%)和资助方对试验设计、实施、分析、报告的参与(58%)。
- 获取缺失信息后,资助方信息充分比例提高32%(133篇中64篇获得所有领域信息),中位耗时13分钟/篇。
- 作者经济利益冲突信息充分报告180篇(90%),获取4篇试验的缺失信息(20%),中位耗时28分钟/篇。
关键数值与推荐
- 资助方信息充分的标准:报告资助方名称、支持类型和资助方参与情况。
- 作者经济利益冲突信息充分的标准:报告组织名称、关系类型和具有经济利益冲突的作者的参与情况。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the adequacy of reporting of funder and authors' financial conflicts of interest information in randomized trial publications of drugs or devices, and to assess to which degree the missing information can be obtained from other sources. STUDY DESIGN AND SETTING: We took a random sample of 200 randomized trial publications indexed in MEDLINE in May 2022. Two authors independently assessed the adequacy of funder and authors' conflicts of interest information. We considered funder information adequate when name of funder(s), type(s) of support, and funder's involvement were reported. Similarly, we considered authors' financial conflicts of interest information adequate when name of organization(s), type of relationship(s), and the involvement of author(s) with financial conflicts of interest were reported. We attempted to obtain missing information through multiple approaches (eg, searching websites, trial registries, and public disclosure databases) and recorded the time taken. RESULTS: We found that information on funder was adequately reported in 67 (34%) trial publications, partly adequate in 110 (55%), inadequate in 12 (6%), and 11 (6%) had no information available. Often, trial publications did not report the type(s) of support (40%) and the funders' involvement in the trial design, conduct, analysis, and reporting (58%). After obtaining missing information, the proportion of trial publications with adequate funder information increased by 32% (we obtained information on all domains for 64 of 133 trial publications) by spending a median time of 13 minutes per trial. Information on authors' financial conflicts of interest was adequately reported in 180 (90%) trial publications, and we obtained the missing information for four trials (20%) by spending a median time of 28 minutes per trial. CONCLUSION: In contemporary trial publications, funder information was rarely adequately reported, whereas authors' financial conflicts of interest information was adequately reported in almost all trial publications. Our approaches for obtaining missing information improved the adequacy of funder and conflicts of interest information. Our approaches were particularly effective in obtaining funder information, whereas efforts to obtain conflicts of interest information were less successful and more time-consuming. Our findings provide context for systematic review authors when deciding if and how to search for missing funder and conflicts of interest information while balancing the need for obtaining information with the time spent searching.
引用
- Broager MI, Faltinsen E, Hróbjartsson A, et al. Funder and authors' financial conflicts of interest information in trial publications: adequacy of reporting and obtaining missing information. J Clin Epidemiol. 2025. PMID: 40222716. doi:10.1016/j.jclinepi.2025.111786
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。